Cover Image
市場調查報告書

無菌注射劑市場 - 全球產業分析,規模,佔有率,成長,趨勢,及預測:2017年∼2025年

Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 603253
出版日期 內容資訊 英文 222 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
無菌注射劑市場 - 全球產業分析,規模,佔有率,成長,趨勢,及預測:2017年∼2025年 Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2018年01月16日 內容資訊: 英文 222 Pages
簡介

無菌注射藥物市場的報告研究了全球市場的現狀和未來前景。本報告的利益相關者包括從事製造、商業化、提供無菌注射藥物產品的公司和中介,以及計劃進入該市場的新進入者。本報告包含詳細的執行摘要以及市場快照,提供研究範圍內考慮的各個細分市場和細分市場的整體訊息。本部分還根據主要類型、應用、使用情況、最終用戶和地區等主要細分市場提供全球無菌注射藥物市場的全面訊息和數據分析。

本報告提供全球無菌注射劑市場相關調查分析,產業分析,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統性資訊。

目錄

第1章 簡介

  • 報告範圍和市場區隔
  • 序文
  • 調查的重點

第2章 前提和調查方法

  • 前提
  • 縮寫
  • 調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 主要產業的發展
  • 無菌注射劑的市場規模預測(10億US美元)
  • 市場機會藍圖
  • 波特分析
  • 無菌注射劑市場預測

第5章 市場動態

  • 成長要素及阻礙因素的概述分析
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 法規方案
  • 開發平台分析
  • M&A及合作
  • 品牌分析
  • 前3名企業

第6章 全球無菌注射劑的市場分析:各類型

  • 主要的觀察
  • 簡介
  • 市場佔有率分析(以金額為準)
  • 市場預測
  • 市場分析
  • 市場魅力分析

第7章 全球無菌注射劑的市場分析:各類藥物

  • 主要的觀察
  • 簡介
  • 市場佔有率分析(以金額為準)
  • 市場預測
  • 市場分析
  • 市場魅力分析

第8章 全球無菌注射劑的市場分析:各症狀

  • 主要的觀察
  • 簡介
  • 市場佔有率分析(以金額為準)
  • 市場預測
  • 市場分析
  • 市場魅力分析

第9章 全球無菌注射劑的市場分析:各銷售管道

  • 主要的觀察
  • 簡介
  • 市場佔有率分析(以金額為準)
  • 市場預測
  • 市場分析
  • 市場魅力分析

第10章 全球無菌注射劑的市場分析:各地區

  • 全球法規方案
  • 市場佔有率分析(以金額為準)
  • 市場預測
  • 市場魅力分析

第11章 北美

第12章 歐洲

第13章 亞太地區

第14章 南美

第15章 中東、非洲地區

第16章 競爭情形

  • 競爭矩陣
  • 市場佔有率分析:2016年(估計)
  • 企業簡介
  • Baxter International
    • 企業概要
  • Sanofi SA
  • Pfizer, Inc.
  • GlaxoSmithKline Plc.
  • AstraZeneca
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • Novo Nordisk A/S
  • Gilead Sciences, Inc.
目錄

Title:
Sterile Injectable Drugs Market (Type - Small Molecule and Large Molecule; Drug Class - Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, and Peptide Antibiotics; Indication - Cardiology and Metabolic Disorders, Neurology, Oncology, Autoimmune, Gastroenterology, Hematology, Pain, and Infectious Diseases; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Ecommerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

This report on sterile injectable drugs market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing sterile injectable drugs products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global sterile injectable drugs market with respect to the leading market segments based on major types, applications, usage, end users, and geographies.

Based on the product type, the sterile injectable drugs market has been segmented into: small and large molecules. In term of indication, it can be segmented into cardiology & metabolic disorders, neurology, oncology, autoimmune, gastroenterology, hematology, pain, infectious diseases and others. On the basis of drug class it can be segmented into monoclonal antibodies, cytokines, peptide hormones, vaccines, peptide antibiotics, insulin, blood factors, immunoglobulin and others,. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, technological advancement, and growing number of use of disposable products in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the sterile injectable drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global sterile injectable drugs market.

Geographically, sterile injectable drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global sterile injectable drugs market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global sterile injectable drugs market. The report also profiles key players operating in the sterile injectable drugs market which are Baxter International Inc., Sanofi, Pfizer Inc., and GlaxoSmithKline plc. AstraZeneca, Gilead, Sciences, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., and Novo Nordisk A/S. The global sterile injectable drugs market is dominated by two global vendors that accounts for around 80% share of the global market.

The global sterile injectable drugs market is segmented as follows:

  • Global Sterile Injectable Drugs Market, by Type
  • Small Molecule
  • Large Molecule
  • Global Sterile Injectable Drugs Market, by Drug Class
  • Monoclonal Antibodies (Mabs)
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccine
  • Immunoglobulins
  • Blood Factors
  • Peptide Antibiotics
  • Others
  • Global Sterile Injectable Drugs Market, by By Indication
  • Cardiology & Metabolic disorders
  • Neurology
  • Oncology
  • Autoimmune
  • Gastroenterology
  • Hematology
  • Pain
  • Infectious diseases
  • Others
  • Global Sterile Injectable Drugs Market, by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce
  • Global Sterile Injectable Drugs Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of the Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope & Market Segmentation
  • 1.2. Preface
  • 1.3. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Developments
  • 4.3. Sterile Injectable Drugs Market Size (US$ Bn) Forecast
  • 4.4. Market Opportunity Map
  • 4.5. Porter's Analysis
  • 4.6. Sterile Injectable Drugs Market Outlook

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities
  • 5.5. Regulatory Scenario
  • 5.6. Pipeline Analysis
  • 5.7. Merger Acquisitions & Collaborations
  • 5.8. Brand Analysis
  • 5.9. Top 3 Players

6. Global Sterile injectable Drugs Market Analysis By Type

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 6.4. Sterile Injectable Drugs Market Forecast By Type
  • 6.5. Sterile Injectable Drugs Market Analysis, by Type
  • 6.6. Sterile Injectable Drugs Market Attractiveness Analysis, by Type

7. Sterile Injectable Drugs Market Analysis, By Drug Class

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 7.4. Sterile Injectable Drugs Market Forecast, By Drug Class
  • 7.5. Sterile Injectable Drugs Market Analysis, By Drug Class
  • 7.6. Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Class

8. Sterile Injectable Drugs Market Analysis, by Indication

  • 8.1. Key Findings
  • 8.2. Introduction
  • 8.3. Sterile Injectable Drugs Market Value Share Analysis, by Indication
  • 8.4. Sterile Injectable Drugs Market Forecast, by Indication
  • 8.5. Sterile Injectable Drugs Market Analysis, by Indication
  • 8.6. Sterile Injectable Drugs Market Attractiveness Analysis, by Indication

9. Sterile Injectable Drugs Market Analysis, By Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
  • 9.3. Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 9.4. Sterile Injectable Drugs Market Forecast, By Distribution Channel
  • 9.5. Sterile Injectable Drugs Market Analysis, By Distribution Channel
  • 9.6. Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel

10. Sterile Injectable Drugs Market Analysis, by Region

  • 10.1. Global Regulatory Scenario
  • 10.2. Sterile Injectable Drugs Market Value Share Analysis, By Region Type
  • 10.3. Sterile Injectable Drugs Market Forecast, By Region Type
  • 10.4. Sterile Injectable Drugs Market Attractiveness Analysis, By Region Type

11. North America Sterile Injectable Drugs Market Analysis

  • 11.1. Key Findings
  • 11.2. North America Sterile Injectable Drugs Market Overview
  • 11.3. North America Sterile Injectable Drugs Market Value Share Analysis, by Country
  • 11.4. North America Sterile Injectable Drugs Market Forecast, by Country
  • 11.5. North America Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 11.6. North America Sterile Injectable Drugs Market Forecast By Type
  • 11.7. North America Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 11.8. North America Sterile Injectable Drugs Market Forecast By Drug Class
  • 11.9. North America Sterile Injectable Drugs Market Value Share Analysis, By Indication
  • 11.10. North America Sterile Injectable Drugs Market Forecast By Indication
  • 11.11. North America Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 11.12. North America Sterile Injectable Drugs Market Forecast By Distribution Channel
  • 11.13. North America Market Attractiveness Analysis
  • 11.14. Market Trends

12. Europe Sterile Injectable Drugs Market Analysis

  • 12.1. Key Findings
  • 12.2. Europe Sterile Injectable Drugs Market Overview
  • 12.3. Europe Sterile Injectable Drugs Market Value Share Analysis, by Country
  • 12.4. Europe Sterile Injectable Drugs Market Forecast, by Country
  • 12.5. Europe Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 12.6. Europe Sterile Injectable Drugs Market Forecast By Type
  • 12.7. Europe Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 12.8. Europe Sterile Injectable Drugs Market Forecast By Drug Class
  • 12.9. Europe Sterile Injectable Drugs Market Value Share Analysis, By Indication
  • 12.10. Europe Sterile Injectable Drugs Market Forecast By Indication
  • 12.11. Europe Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 12.12. Europe Sterile Injectable Drugs Market Forecast By Distribution Channel
  • 12.13. Europe Market Attractiveness Analysis
  • 12.14. Market Trends

13. Asia Pacific Sterile Injectable Drugs Market Analysis

  • 13.1. Key Findings
  • 13.2. Asia Pacific Sterile Injectable Drugs Market Overview
  • 13.3. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, by Country
  • 13.4. Asia Pacific Sterile Injectable Drugs Market Forecast, by Country
  • 13.5. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 13.6. Asia Pacific Sterile Injectable Drugs Market Forecast By Type
  • 13.7. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 13.8. Asia Pacific Sterile Injectable Drugs Market Forecast By Drug Class
  • 13.9. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Indication
  • 13.10. Asia Pacific Sterile Injectable Drugs Market Forecast By Indication
  • 13.11. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 13.12. Asia Pacific Sterile Injectable Drugs Market Forecast By Distribution Channel
  • 13.13. Asia Pacific Market Attractiveness Analysis
  • 13.14. Market Trends

14. Latin America Sterile Injectable Drugs Market Analysis

  • 14.1. Key Findings
  • 14.2. Latin America Sterile Injectable Drugs Market Overview
  • 14.3. Latin America Sterile Injectable Drugs Market Value Share Analysis, by Country
  • 14.4. Latin America Sterile Injectable Drugs Market Forecast, by Country
  • 14.5. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 14.6. Latin America Sterile Injectable Drugs Market Forecast By Type
  • 14.7. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 14.8. Latin America Sterile Injectable Drugs Market Forecast By Drug Class
  • 14.9. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Indication
  • 14.10. Latin America Sterile Injectable Drugs Market Forecast By Indication
  • 14.11. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 14.12. Latin America Sterile Injectable Drugs Market Forecast By Distribution Channel
  • 14.13. Latin America Market Attractiveness Analysis
  • 14.14. Market Trends

15. Middle East & Africa Sterile Injectable Drugs Market Analysis

  • 15.1. Key Findings
  • 15.2. Middle East & Africa Sterile Injectable Drugs Market Overview
  • 15.3. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, by Country
  • 15.4. Middle East & Africa Sterile Injectable Drugs Market Forecast, by Country
  • 15.5. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Type
  • 15.6. Middle East & Africa Sterile Injectable Drugs Market Forecast By Type
  • 15.7. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
  • 15.8. Middle East & Africa Sterile Injectable Drugs Market Forecast By Drug Class
  • 15.9. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Indication
  • 15.10. Middle East & Africa Sterile Injectable Drugs Market Forecast By Indication
  • 15.11. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
  • 15.12. Middle East & Africa Sterile Injectable Drugs Market Forecast By Distribution Channel
  • 15.13. Middle East & Africa Market Attractiveness Analysis
  • 15.14. Market Trends

16. Competition Landscape

  • 16.1. Competition Matrix
  • 16.2. Sterile Injectable Drugs Market Share Analysis, by Company, 2016 (Estimated)
  • 16.3. Company Profile
  • 16.4. Baxter International
    • 16.4.1. Company Details
    • 16.4.2. Business Overview
    • 16.4.3. Financial Overview
    • 16.4.4. Strategic Overview
    • 16.4.5. SWOT Analysis
  • 16.5. Sanofi S.A.
    • 16.5.1. Company Details
    • 16.5.2. Business Overview
    • 16.5.3. Financial Overview
    • 16.5.4. Strategic Overview
    • 16.5.5. SWOT Analysis
  • 16.6. Pfizer, Inc.
    • 16.6.1. Company Details
    • 16.6.2. Business Overview
    • 16.6.3. Financial Overview
    • 16.6.4. Strategic Overview
    • 16.6.5. SWOT Analysis
  • 16.7. GlaxoSmithKline Plc.
    • 16.7.1. Company Details
    • 16.7.2. Business Overview
    • 16.7.3. Financial Overview
    • 16.7.4. Strategic Overview
    • 16.7.5. SWOT Analysis
  • 16.8. AstraZeneca
    • 16.8.1. Company Details
    • 16.8.2. Business Overview
    • 16.8.3. Financial Overview
    • 16.8.4. Strategic Overview
    • 16.8.5. SWOT Analysis
  • 16.9. Merck & Co., Inc.
    • 16.9.1. Company Details
    • 16.9.2. Business Overview
    • 16.9.3. Financial Overview
    • 16.9.4. Strategic Overview
    • 16.9.5. SWOT Analysis
  • 16.10. Novartis AG
    • 16.10.1. Company Details
    • 16.10.2. Business Overview
    • 16.10.3. Financial Overview
    • 16.10.4. Strategic Overview
    • 16.10.5. SWOT Analysis
  • 16.11. Johnson & Johnson Services, Inc.
    • 16.11.1. Company Details
    • 16.11.2. Business Overview
    • 16.11.3. Financial Overview
    • 16.11.4. Strategic Overview
    • 16.11.5. SWOT Analysis
  • 16.12. Novo Nordisk A/S
    • 16.12.1. Company Details
    • 16.12.2. Business Overview
    • 16.12.3. Financial Overview
    • 16.12.4. Strategic Overview
    • 16.12.5. SWOT Analysis
  • 16.13. Gilead Sciences, Inc.
    • 16.13.1. Company Details
    • 16.13.2. Business Overview
    • 16.13.3. Financial Overview
    • 16.13.4. Strategic Overview
    • 16.13.5. SWOT Analysis

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 03: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 05: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Indication, 2017-2025
  • Table 06: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025
  • Table 08: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Region Type, 2015-2025
  • Table 09: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015-2025
  • Table 10: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 11: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 12: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017-2025
  • Table 13: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025
  • Table 14: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015-2025
  • Table 15: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 16: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 17: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017-2025
  • Table 18: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025
  • Table 19: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015-2025
  • Table 20: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 21: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 22: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017-2025
  • Table 23: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025
  • Table 24: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015-2025
  • Table 25: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 26: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 27: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017-2025
  • Table 28: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025
  • Table 29: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015-2025
  • Table 30: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017-2025
  • Table 31: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017-2025
  • Table 32: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017-2025
  • Table 33: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017-2025

List of Figures

  • Figure 01: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, 2015-2025
  • Figure 02: Global Sterile Injectable Drugs Market Value Share Analysis by Type, 2017 and 2025
  • Figure 03: Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015-2025
  • Figure 04: Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015-2025
  • Figure 05: Sterile Injectable Drugs Market Attractiveness Analysis by Type
  • Figure 06: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Monoclonal Antibodies, 2015-2025
  • Figure 07: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cytokines, 2015-2025
  • Figure 08: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Insulin, 2015-2025
  • Figure 09: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Hormones, 2015-2025
  • Figure 10: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Vaccine, 2015-2025
  • Figure 11: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Immunoglobulin, 2015-2025
  • Figure 12: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Blood Factors, 2015-2025
  • Figure 13: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Antibiotics, 2015-2025
  • Figure 14: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015-2025
  • Figure 15: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025 Content
  • Figure 16: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cardiology & Metabolic disorders, 2015-2025
  • Figure 17: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Neurology, 2015-2025
  • Figure 18: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Oncology, 2015-2025
  • Figure 19: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Autoimmune, 2015-2025
  • Figure 20: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Gastroenterology, 2015-2025
  • Figure 21: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hematology, 2015-2025
  • Figure 22: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Pain, 2015-2025
  • Figure 23: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Infectious diseases, 2015-2025
  • Figure 24: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015-2025
  • Figure 25: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 26: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hospital Pharmacy, 2015-2025
  • Figure 27: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Retail Pharmacy, 2015-2025
  • Figure 28: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by E-commerce, 2015-2025
  • Figure 29: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution Channel, 2015-2025
  • Figure 30: Global Sterile Injectable Drugs Market Value Share Analysis by Region Type, 2017 and 2025
  • Figure 31: Sterile Injectable Drugs Market Attractiveness Analysis, by Region Type
  • Figure 32: North America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 33: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 35: North America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 36: North America Market Value Share Analysis by Type, 2016 and 2025
  • Figure 37: North America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 38: North America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 39: North America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 40: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015-2025
  • Figure 41: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025
  • Figure 42: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 43: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015-2025
  • Figure 44: Europe Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 45: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 46: Europe Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 47: Europe Market Value Share Analysis by Type, 2016 and 2025
  • Figure 48: Europe Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 49: Europe Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 50: Europe Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 51: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015-2025
  • Figure 52: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025
  • Figure 53: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 54: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015-2025
  • Figure 55: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 56: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 57: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 58: Asia Pacific Market Value Share Analysis by Type, 2016 and 2025
  • Figure 59: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 60: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 61: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 62: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015-2025
  • Figure 63: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025
  • Figure 64: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 65: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015-2025
  • Figure 66: Latin America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 67: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 68: Latin America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 69: Latin America Market Value Share Analysis by Type, 2016 and 2025
  • Figure 70: Latin America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 71: Latin America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 72: Latin America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 73: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015-2025
  • Figure 74: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025
  • Figure 75: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 76: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015-2025
  • Figure 77: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 78: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 79: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 80: Middle East & Africa Market Value Share Analysis by Type, 2016 and 2025
  • Figure 81: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 82: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 83: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 84: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015-2025
  • Figure 85: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015-2025
  • Figure 86: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 87: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015-2025
  • Figure 88: Heat Map Analysis by Company (2016)
Back to Top